Login to Your Account


RESEARCH 'WAVE CRESTING,' SAYS CEO

Hemispherx Biopharma Inc. CEO Thomas Equels told BioWorld Today that the approval in the Argentine Republic of rintatolimod for severe ME/CFS is “the opening of a door” to the rest of the world, which is waking up to the reality of the disease.

more »